Prime Medicine, Inc. (PRME) Discusses Liver Disease Franchise Strategy With Focus on Wilson Disease Transcript

Group 1 - The core focus of the event is on Prime Medicine's strategy for addressing Wilson disease, highlighting the potential of their Prime Editors to provide durable cures for patients [1] - The event features insights from key opinion leaders and the management team, emphasizing the opportunity within the liver disease franchise [1] - The CEO, Allan Reine, will introduce Prime Medicine and contextualize Wilson disease as a central element of their strategy, discussing the global market opportunity [3] Group 2 - The presentation will include forward-looking statements that are subject to risks and uncertainties, which could lead to actual results differing from those described [2] - The event will be recorded, and the recording will be accessible on the company's Investor Relations website [2] - Slides referenced during the presentation will be available within the webcast and on the company's website [2]